660399-53-1

Basic information

• Product Name: Benzoic acid, 4-[(6-iodo-4-oxo-3(4H)-quinazolinyl)methyl]-, 1,1-dimethylethyl ester
• CAS NO: 660399-53-1
• Molecular Formula: C20H19IN2O3
• Molecular Weight: 462.287
• Mol File: 660399-53-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-[(6-iodo-4-oxo-3(4H)-quinazolinyl)methyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[(6-iodo-4-oxo-3(4H)-quinazolinyl)methyl]-, 1,1-dimethylethyl ester(660399-53-1)
• EPA Substance Registry System: Benzoic acid, 4-[(6-iodo-4-oxo-3(4H)-quinazolinyl)methyl]-, 1,1-dimethylethyl ester(660399-53-1)

Safety Data

• Hazardous Substances Data: 660399-53-1(Hazardous Substances Data)

Upstream product

• 16064-08-7 6-iodoquinazolin-4(3H)-one 
• 108052-76-2 4-(bromomethyl)benzoic acid 1,1-dimethylethyl ester 

Downstream Products

• 660399-56-4 tert-butyl 4-{4-oxo-6-[3-(4-methoxyphenyl)-prop-1-ynyl]-4H-quinazolin-3-ylmethyl}-benzoate 
• 602167-12-4 tert-Butyl 4-[4-oxo-6-(3-phenyl-prop-1-ynyl)-4H-quinazoline-3-ylmethyl]-benzoate 

Relevant articles and documents

Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

Quinazolinones 8 and pyrido[3,4-d]pyrimidin-4-ones 9 as orally active and specific matrix metalloproteinase-13 inhibitors were discovered for the treatment of osteoarthritis. Starting from a high-through-put screening (HTS) hit thizolopyrimidin-dione 7, w

Oxo-azabicyclic compounds

A compound selected from those of formula (I): wherein: X1, X2, and X3, represent N or —CR3in which R3is as described in the description, G1represents a group selected from those of formula